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was recognized as a Master’s program by the Saudi Commission for Health Specialties. Our ge-
netic counselors combine their knowledge of genetics, counseling theory and interpersonal
communication to serve Saudi and non-Saudi patients affected with a range of genetic condi-
tions and/or birth defects. Most patients are referred to the clinic from different clinics at King
Faisal Specialist Hospital and Research Centre (KFSHRC) and outside of KFSHRC for various in-
dications. Carrier testing and preventative reproduction options rank highly on the reasons for
referral to our clinics.
The Saudi population has unique customs and beliefs, such as consanguinity and the evil eye.
Challenges that are routinely encountered in our genetic counseling clinics include, but are not
limited to, preventative reproductive options and termination of pregnancy, manifesting car-
riers, stigmatization of women and approaches to complex molecular findings. Working with
families from different backgrounds and beliefs undoubtedly requires professionals with a
distinctive set of skills and a structured clinical setting. This review article presents the scope
of genetic counseling practice and tackles some of the challenges faced in providing genetic
counseling in Saudi Arabia.
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The term “genetic counseling” was first introduced in
1947 by Sheldon Reed [1]. The American Society of Human
Genetics proposed a definition of genetic counseling in
1975, which was redefined after the professional society
of genetic counselors known as “The National Society of
Genetic Counselors” was incorporated in 1979. Genetic
counseling is a “process of helping people understand and
adapt to the medical, psychological and familial implica-
tions of genetic contributions to disease” [2]. The first
genetic counseling program was established by Professor
Melissa Richter in 1969 at Sarah Lawrence College, which
is located in New York, in the United States [3]. At pre-
sent, there are several genetic counseling Master’s pro-
grams in the United States, Canada, Europe and South
Africa.
Training in genetic counseling was not available in the
Middle Eastern countries until 2003, when the late Pro-
fessor Ahmed Teebi was hired by King Faisal Specialist
Hospital and Research Center (KFSHRC) as Head of the
Department of Genetics. He championed the develop-
ment of a training program in the kingdom and hired a
Canadian genetic counselor, Shelley Kennedy, as super-
visor of the program to develop its curriculum. One year
later, with Professor Moeenaldeen Al-Sayed, as Medical
Director, a diploma in genetic counseling was established
at KFSHRC in Riyadh, Saudi Arabia [4]. Nine years later,
Saudi Arabia witnessed the birth of a Master’s program in
genetic counseling. As an expansion of the successful
development of this field in Saudi Arabia, the Master’s
program in genetic counseling was recognized and
accredited by the Saudi Commission for Health Specialties
in 2015. The inclusion of this Master’s program in the
Ministry of Higher Education in Saudi Arabia will provide
genetic counselors throughout the Kingdom, which will
alleviate the burden placed on non-geneticist health care
providers who have little training in medical genetics. The
availability of genetic counselors in many of the govern-
mental hospitals in the Kingdom of Saudi Arabia will
provide tremendous advantages to patients and to other
health care providers. This article reviews the genetic
counselor’s scope of practice at KFSHRC, placing partic-
ular emphasis on the challenges encountered in our ge-
netic counseling service.
1.1. Genetic counselors’ scope of practice
Genetic counselors are Master’s trained health care pro-
fessionals who combine their knowledge of basic science,
medical genetics, epidemiological principles, counseling
theory with their skills in genetic risk assessment, educa-
tion, interpersonal communication and counseling to pro-
vide services to patients and their families for a diverse set
of genetic or genomic indications. Some genetic counselors
offer general genetic counseling, while others sub-
specialize in a particular area of interest, such as cancer
or prenatal care, assisted reproduction, cardiovascular
health, research, public health and education.
Genetic counselors see patients and their families for
several reasons, including but not limited to, a familyhistory of an inherited condition, a previous child with
intellectual disability, multiple congenital anomalies or
birth defects, repeated pregnancy loss or infertility, a
positive newborn screening test, a newly diagnosed ab-
normality or genetic condition and to enroll patients in
research studies. Moreover, they provide carrier testing,
premarital genetic testing and counseling regarding pre-
ventative reproductive options, which include prenatal
diagnosis (PND) and pre-implantation genetic diagnosis
(PGD) for various underlying genetic defects and chro-
mosomal abnormalities.
1.2. Genetic counseling clinics: the KFSHRC
experience
Our genetic counseling clinics serve patients from different
provinces of Saudi Arabia, the gulf and Arab countries. We
have six genetic counseling clinics per week. These clinics
are separate from the genetic and metabolic clinics, which
are operated by geneticists. The time allocated for each
patient ranges from 25 min for a follow-up to 75 min for a
new case. Some cases require multiple counseling sessions,
whereas other cases require only one or two visits to the
genetic counseling clinic.
Cases are referred to our clinics from different spe-
cialties both within and outside of KFSHRC, such as medical
genetics, high risk obstetric gynecology, cancer, derma-
tology, neurology, hematology, pediatrics and in vitro
fertilization clinics. Referrals are primarily for extensive
genetic counseling, molecular and cytogenetic testing,
premarital screening, carrier testing and preventative
reproductive options.
Many families seek genetic counseling to understand the
nature and consequences of genetic conditions, the risk of
recurrence and preventative reproductive options and to
address their uncertainty regarding genetics and inheri-
tance. Our teams provide support for these families by
identifying their concerns, addressing their needs,
providing psychosocial counseling and promoting their
decision-making process regarding testing or methods of
prevention.
2. Challenges in genetic counseling services:
the KFSHRC experience
Genetic counseling often raises ethical and professional
challenges. The most frequently encountered challenges
among physicians in Western countries such as in Austria
have been informed consent, organizational constraints,
withholding information, and attaining/maintaining profi-
ciency. [5].
The major ethical principles that govern the attitudes of
genetic counselors include respect for the patients’ au-
tonomy and right to make their own decisions, beneficence,
i.e., taking actions to help others, non-maleficence, i.e., to
do no harm, and justice, or administering services fairly
between others [6].
There are several unique and difficult issues that are
faced routinely in genetic counseling clinics in Saudi Arabia.
Below is an overview of these issues based on several ex-
periences at KFSHRC.
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Consanguineous marriage is a common practice in Saudi
Arabia. Consanguinity refers to the marriage of parents
with a recent common ancestor [7]. The overall prevalence
of consanguineous marriage in Saudi Arabia is 56% and is
33.6% between first-degree cousins [8]. When families with
a positive family history for an autosomal recessive condi-
tion are seen for genetic counseling, the role of consan-
guinity in increasing the chances of having children with
genetic disease is always discussed; however, most of the
time these families continue practicing consanguineous
marriage and have more affected children. In addition, it is
not uncommon to see more than one genetic disease
segregate with a family.
In Saudi Arabia, the high rate of consanguinity may be
attributed to different social and traditional factors, in
addition to the desire to keep property within families.
Main factors that inspire consanguinity include social and
economic benefits and the stability of marriage between
cousins. When the man and woman are raised in the same
or a similar family environment, it is believed that they will
adjust more easily to the marriage. In addition, marriage
between relatives is considered to be beneficial because it
maintains family fortunes within the same family structure.
Anthropologists have long agreed that the primary
achievement of consanguineous marriages is the inheri-
tance of family structure and property [9e11]. Another
cultural belief is in polygamy, which the husbands in some
Saudi families believe is the practical solution to this
situation.
2.2. The evil eye
The evil eye is a “folk belief elicited by the good luck of
fortunate people whether in the form of material pos-
sessions including livestock, or possessing beauty, health,
or offspring, may result in their misfortune” (Evil eye
Encyclopedia). Some families relate their children’s
inherited disease to belief in the evil eye. The evil eye
belief is widespread, according to which people can cause
harm by merely an envious glance at desired objects or
their owners [12]. The belief in the evil eye is ancient and
present in every culture. The oldest reference appears in
the cuneiform texts of the Sumerians, Babylonians and
Assyrians around 3000 BC (Ancient History Encyclopedia).
At that time, it was called “drishti” or “nazar” in India,
and it was also called “nazar” in Turkey. Some people
believe that the evil eye can place a curse on victims
through a malevolent gaze of their magical eye. Others
believe that envying others through the use of the evil eye
can happen unintentionally. Furthermore, some cultures
believe that the evil eye can suddenly bring bad luck by
looking unintentionally at people who are unlucky enough
to be cursed with the power. The evil eye was mentioned
in the Quran in Sorat Al-Nisa verse: “or envy people for
what God has given them of His bounty gave Ibrahim the
Book and Wisdom and gave him the great king”. In Islam,
Prophet Muhammad states: “The influence of an evil eye is
a fact.” All Muslims believe in the evil eye because it is
mentioned in the Quran. Some of the families at thegenetic counseling clinics explained that they expected
the disease to be caused by the evil eye. According to
some health care providers, others held this belief but
they did not share it.
2.3. Preventative reproductive options and
termination of pregnancy
Preventative reproductive strategies are urgently needed
to combat the medical, financial and social burden of ge-
netic diseases in Saudi Arabia. Preventative reproductive
options are governed by religious rulings and/or political
influence worldwide. While PGD and PND diagnoses are
permitted in majority of countries worldwide, the practice
of PGD is prohibited in Germany to protect embryos
[13,14].
In the past few years, several studies have been con-
ducted in Saudi Arabia to compare the Saudi preference
for PGD versus PND. In a study conducted in 2006, 30
couples who had been treated at KFSHRC were surveyed
regarding their attitudes towards preventative reproduc-
tive options. It was found that 27% of the couples
preferred PGD compared to 13% who accepted PND. In
addition, 10% were reluctant to choose any preventative
options [15]. Similar findings were observed in a study
conducted with a Lebanese population that examined
their attitudes towards PGD as an alternative option to
PND. The results indicated that 68% of the participating
women accepted PGD [16]. The factors that contributed to
the avoidance of PGD included receiving an IVF procedure,
long waiting lists, fear of mixing embryos, the possibility
of misdiagnosis and/or failure to conceive. However, the
aforementioned studies showed an overall preference for
PGD compared with PND primarily due to religious rulings
that govern the termination of pregnancy in Arab
countries.
The potential benefits of PGD are not confined to pre-
venting the occurrence of genetic disease; they expand to
include advantages that are strongly valued by families. One
advantage is the use of unaffected IVF-embryos for affected
siblings who would benefit from hematopoietic stem cell
transplantation for different genetic diseases, such as Fan-
coni Anemia and hemoglobinopathies [17]. Another benefit
is the use of sex selection for medical reasons, e.g., in case
of an affected child with X-linked conditions. This practice is
permitted in Islam [18]. However, some families request sex
selection in genetic counseling session because of social
preferences, which is not accepted in Saudi Arabia. Simi-
larly, sex selection for social reasons is prohibited in other
countries, such as in Turkey [19].
Prenatal diagnoses are accepted in Islam before 120 days
of conception if the fetus is grossly malformed with an
untreatable severe condition and are based on the parent’s
request [20]. Cases that receive consensus by three ge-
neticists can be terminated before 120 days; other patients
that do not fulfill the criteria for termination of pregnancy
are provided with a letter describing the medical aspects of
the disease to seek support from scholars by getting a
Fatwa. PND and termination of an affected pregnancy
present a real challenge to genetic counselors, geneticists
and maternal fetal medicine consultants, especially when
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trimester and/or with a lack of identifiable pathogenic
mutations underlying the cause of the index case.
A study conducted with 32 families with hemoglobinop-
athies to explore their attitudes towards PND and termina-
tion of pregnancy found that 81.3% of the families accepted
PND. However, termination of pregnancy was viewed
differently because of religious differences, and no other
factors were identified to contribute to the families’ de-
cisions [21]. Another study included a survey of 200 parents
of affected Saudi children and explored their views on
termination of pregnancy for 30 genetic conditions. The re-
sults indicated that mothers were more interested in
termination of pregnancy than fathers of the patients [22].
Overall, PND is widely accepted by the Saudi population, but
termination of pregnancy remains a dilemma for some
families. Pregnancy at the time of mutation analysis is also
common in Saudi Arabia. At the genetic counseling clinic, we
routinely meet couples and review the preventative options
with them. However, couples often indicate that an un-
planned pregnancy has occurred. A similar problem arose
when families were referred to the PGD clinic; this indicates
lack of proper use of contraception, either intentionally or
unintentionally.
Mitochondrial diseases due to mtDNA defects are a
challenging category of genetic disease that present to
genetic counseling for preventative reproductive options.
The reasons these cases are difficult include social stigma
for carrier mothers and technical limitations of PGD appli-
cation. Tissue specificity, heteroplasmy, mutant load and
bottleneck effect are barriers to performing PGD with no
residual risk of recurrence for a concerned family [23]. The
situation is different in Western countries such as in the UK,
where parents of an affected child with an mtDNA defect
have alternatives to PGD. These alternatives include oocyte
donation and embryo manipulation to replace the defective
mtDNA with unaffected mtDNA through different mito-
chondrial gene replacement techniques that have been
approved ethically and legally (http://www.nuffieldb
ioethics.org/mitochondrial-dna-disorders) [24,25]. Both
approaches are prohibited in Islam [26,27]. Accordingly,
these families suffer physically and psychosocially due to
their limited reproductive options in Saudi Arabia.
2.4. Manifesting carriers
Our society is highly inbred, favoring first cousin mar-
riages [28]. Therefore, most of our patients are affected
with autosomal recessive conditions, in particular inborn
errors of metabolism [29]. The carriers for autosomal
recessive or X-linked conditions are typically asymptom-
atic. However, it is known that heterozygous individuals
may manifest some signs of disease based on biochem-
ical, radiological and clinical findings. Examples include
hyperammonemia in case of carriers for X-linked condi-
tions, ornithine transcarbamylase deficiency, calvarial
thickening in heterozygote individuals with autosomal
recessive disorders, Marshall syndrome reported by Kha-
lifa et al [30] and phenotypic spectrums seen in hetero-
zygotes for familial Mediterranean fever. The question
that becomes apparent is whether we should provide
management and treatment for the manifestingheterozygotes. This demonstrates the crucial role of ge-
netic counselors in providing pre-test and post-test
counseling to enable these individuals to understand the
implications of genetic testing and to adapt physically
and cope psychosocially to carrier test results. Without
proper education and counseling, this could lead to al-
terations in parenting, increased anxiety, negative self-
concept and stigmatization. In Western countries, addi-
tional burdens on manifesting carriers include health in-
surance and/or employment discrimination [31].
Carrier testing identifies heterozygote individuals with
autosomal recessive and X-linked conditions; these findings
indicate additional family members who are at-risk for
manifesting signs of the disease and/or having affected
children, which elicits a complex counseling session. Ataxia
telangiectasia (AT) is an autosomal recessive condition
affecting 1:40,000e1:100,000 live births in the United
States. Carriers of AT are at a four-fold increased risk of
developing cancer and heart disease in comparison to
general population [32]. AT carriers are often hypersensi-
tive to radiation and radiomimetic drugs. Genotypeephe-
notype correlation may provide insight into at-risk carriers’
predisposition to cancer. However, the lack of reported
correlation between a novel genetic alteration and the risks
mentioned above complicates genetic counseling. This ul-
timately affects individual’s ability to make an informed
decision regarding management. Urgent issues such as
parental surveillance, referral to other specialties and
carrier testing for unaffected offspring emerge and chal-
lenge the entire genetic counseling process.
2.5. Emotional and social impact on carrier women
The emotional and social impact on parents with X-linked
conditions differs from that of parents with recessive dis-
eases. In a study conducted by James et al [33], they found
that carrier mothers of X-linked conditions experienced
more guilt, anger and self-blame while parents of children
with autosomal recessive conditions worried more about
reproductive risk. The social burden on female carriers in
form of stigmatization is no longer a phenomenon that is
uniquely related to X-linked conditions or mitochondrial
disease due to maternal inheritance, as previously
believed. Our clinical experience expands that list to
include carrier mothers for autosomal recessive conditions.
We believe that the stigmatization of carrier mothers of
autosomal recessive conditions in our community is deter-
mined by the lack of adequate knowledge regarding the
inheritance and etiology of the disease, the education level
of the parents and social influence.
The diagnosis of carrier status in mothers of affected
boys with X-linked conditions has been found to affect their
relationship with their daughters. Some mothers have re-
ported a feeling of closeness, which enabled them to talk
openly with their daughters, while others found that the
results of the carrier test drove them apart [34]. In our
population, the stigmatization that occurs when mothers
receive a positive carrier test result may, in their opinion,
justify mothers’ choice to not inform at-risk daughters
about the availability of genetic testing. Mothers who
experience stigma from their husbands and relatives show
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from their daughters. These mothers clearly indicate that
the underlying reason for their behavior is fear for their
daughter’s future (Personal communications).
One of the dilemmas we face in genetic counseling clinic
is requesting carrier testing for the fiance´ of a carrier fe-
male. In our clinical practice, the father of a carrier female
brings the fiance´ and requests us to perform carrier testing
on him without providing information about the genetic
disease in question. Nevertheless, some fiance´s attend ge-
netic counseling clinics unaware about the genetic condi-
tion in the female’s family. This imposes a great challenge
on the genetic counselors, who must value the ethical
principles in practice for all of the involved parties while
considering the burden placed on the woman’s family, the
confidentiality of the woman’s test result and the right of
the fiance´ to be fully counseled before having the genetic
test performed.
2.6. Complex molecular test findings
Advances in molecular testing have benefited families
because it resolves the ambiguity associated with undiag-
nosed cases. It has simultaneously provided opportunities to
extended family members to pursue premarital screening
and to parents to pursue preventative reproductive options.
In spite of these perceived benefits, advances in genetic
testing will continue to become more complex [35]. In
particular, exome sequencing presents challenges to genetic
counselors. Examples of issues encountered in our routine
clinical practice include the identification of variants of un-
known clinical significance, which limits our ability to offer
PND and termination of pregnancy, and the identification of
pathogenic mutations in multiple genes causing a number of
genetic conditions in a family. This certainly warrants careful
and thorough genetic counseling. The major dilemma in
these findings is related to PGD, as only two mutations are
tested using the PGD approach. This places a large burden on
geneticist to carefully review each case with the family and
choose two candidate diseases for PGD based on several
parameters, such as a disease severity and prognostic
outcome. In such cases, PND would be offered to detect
other causative mutations that would not be excluded by
PGD, in the event that the pregnancy continued after PGD.
The decision-making process for the parents becomes
increasingly difficult as other issues arise, e.g., identifying
at-risk family members and cascade genetic testing. Another
issue encountered in the clinic was receiving negative results
of exome sequencing, which required further consideration
of reanalyzing the patient’s sample with a platform charac-
terized by in-depth coverage, homozygosity mapping if
multiple affected family members are available or the use of
another alternative molecular approach. Finally, incidental
findings and ethical challenges of whether to report such
findings were another challenge faced. The application of
guidelines developed by The American College of Medical
Genetics and Genomics (ACMG) helps address this dilemma
and emphasizes the importance of pre-test genetic coun-
seling in the era of exome sequencing [36]. It becomes
apparent that the results from advanced molecular tech-
nologies in the field of medical genetics provide additionalcomplexity to the already complex family situation and
reproductive history.
3. Conclusion
Marriage customs in Saudi Arabia present challenges to
genetic counselors, as multiple diseases can segregate
within a single family. This practice warrants cascade ge-
netic testing for extended family members and raises
ethical challenges. Genetic counseling becomes a very
complex process in view of the available advanced molec-
ular techniques and a lack of clinical significance of the
reported variants. The profession of genetic counseling in
the kingdom will continue to evolve to incorporate growing
complexity due to molecular advances while addressing the
unique social and cultural norms of the region.Conflict of interest
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